NYSE : CHE
Chemed Corporation — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 541.92 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.05B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.93B |
| Enterprise Value | 7.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Aug 17, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 13.02M |
| Shares Outstanding | 12.96M |
| Shares Change (YoY) | -8.29% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 99.34% |
| Float | 11.85M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 25.55 |
| Forward PE | 19.76 |
| PS Ratio | 2.60 |
| Forward PS | 2.41 |
| PB Ratio | 8.04 |
| P/TBV Ratio | 248.63 |
| P/FCF Ratio | 23.46 |
| P/OCF Ratio | 19.08 |
| PEG Ratio | 1.81 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.76 |
| EV / Sales | 2.73 |
| EV / EBITDA | 16.37 |
| EV / EBIT | 19.08 |
| EV / FCF | 24.62 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.11 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 1.33 |
| Interest Coverage | 77.48 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 29.14% |
| Return on Assets (ROA) | 14.26% |
| Return on Invested Capital (ROIC) | 24.58% |
| Return on Capital Employed (ROCE) | 27.47% |
| Weighted Average Cost of Capital (WACC) | 6.64% |
| Revenue Per Employee | $168,303 |
| Profits Per Employee | $17,861 |
| Employee Count | 15,811 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 221.26 |
Taxes
| Measure | Value |
|---|
| Income Tax | 99.92M |
| Effective Tax Rate | 26.13% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +14.86% |
| 50-Day Moving Average | 514.74 |
| 200-Day Moving Average | 462.76 |
| Relative Strength Index (RSI) | 61.79 |
| Average Volume (20 Days) | 144,701 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 685,972 |
| Short Previous Month | 653,250 |
| Short % of Shares Out | 5.29% |
| Short % of Float | 5.79% |
| Short Ratio (days to cover) | 4.25 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.66B |
| Gross Profit | 892.52M |
| Operating Income | 381.13M |
| Pretax Income | 382.32M |
| Net Income | 282.40M |
| EBITDA | 444.42M |
| EBIT | 381.13M |
| Earnings Per Share (EPS) | $20.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 48.43M |
| Total Debt | 392.19M |
| Net Cash | -343.77M |
| Net Cash Per Share | -$26.53 |
| Equity (Book Value) | 861.42M |
| Book Value Per Share | 66.47 |
| Working Capital | 34.79M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 363.16M |
| Capital Expenditures | -67.70M |
| Depreciation & Amortization | 63.29M |
| Net Borrowing | 253.18M |
| Free Cash Flow | 295.45M |
| FCF Per Share | $22.80 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.54% |
| Operating Margin | 14.32% |
| Pretax Margin | 14.37% |
| Profit Margin | 10.61% |
| EBITDA Margin | 16.70% |
| EBIT Margin | 14.32% |
| FCF Margin | 11.10% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.80 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | 19.05% |
| Years of Dividend Growth | 17 |
| Payout Ratio | 11.94% |
| FCF Payout Ratio | 10.97% |
| Buyback Yield | 8.29% |
| Shareholder Yield | 8.81% |
| Earnings Yield | 3.91% |
| FCF Yield | 4.26% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $617.00 |
| Price Target Difference | 15.39% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.57% |
| EPS Growth Forecast (3Y) | 11.95% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 9.16 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |